The authors regret that the following Patient Consent Statement was missing from the above article:
Patient Consent
The hospital ethics committee at Aarhus University Hospital confirm that the experiments and protocols were reviewed and approved.
The authors would like to apologise for any inconvenience caused.
Article info
Publication history
Published online: January 11, 2023
Identification
Copyright
© 2021 The Author(s). Published by Elsevier B.V. on behalf of European Society for Radiotherapy & Oncology.
User license
Creative Commons Attribution – NonCommercial – NoDerivs (CC BY-NC-ND 4.0) | How you can reuse 
Elsevier's open access license policy
Creative Commons Attribution – NonCommercial – NoDerivs (CC BY-NC-ND 4.0)
Permitted
For non-commercial purposes:
- Read, print & download
- Redistribute or republish the final article
- Text & data mine
- Translate the article (private use only, not for distribution)
- Reuse portions or extracts from the article in other works
Not Permitted
- Sell or re-use for commercial purposes
- Distribute translations or adaptations of the article
Elsevier's open access license policy
ScienceDirect
Access this article on ScienceDirectLinked Article
- Two compound techniques for total body irradiationTechnical Innovations and Patient Support in Radiation Oncology Vol. 21
- PreviewHigh-dose total body irradiation (TBI) is a radiotherapy modality in which the whole body is irradiated. Typically, the body is irradiated to a mean of 12–15 Gray (Gy) in 8–12 fractions with one to three fractions a day over three to six days [1-6]. This modality is a part of the treatment of systemic hematologic malignancies [1-5,7]. Chemotherapy and bone marrow transplantation are an effective treatment regimen in combination with TBI [8,9]. However, side effects have to be considered [2,5,10-12].
- Full-Text
- Preview
